title: [Clinical prognosis of drug-susceptible chronic hepatitis B virus patients at year 5 of lamivudine monotherapy].
authors.affiliation: Department of Infectious Diseases, No. 1 Hospital in Lanzhou, China. zhangliyr10@126.com
authors.forename: Yue-rong
authors.initials: YR
authors.lastname: Zhang
authors.forename: Wan-chun
authors.initials: WC
authors.lastname: Yan
authors.forename: Yue-ping
authors.initials: YP
authors.lastname: Zhang
authors.forename: Jian-zhong
authors.initials: JZ
authors.lastname: Jiao
authors.forename: Tao
authors.initials: T
authors.lastname: Zhang
authors.forename: Xiang-lin
authors.initials: XL
authors.lastname: Li
authors.forename: Li-yang
authors.initials: LY
authors.lastname: Wu
authors.forename: Shi-fang
authors.initials: SF
authors.lastname: Wei
mesh_terms: D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D024882:Drug Resistance, Viral / Q000187:drug effects; D005260:Female; D006515:Hepatitis B virus / Q000187:drug effects; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D000998:Antiviral Agents; D019259:Lamivudine